Related Experiment Video
Updated: Dec 24, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding Mode
Thomas Hanke1, Sun-Yee Cheung1, Whitney Kilu1
1Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
Abstract:
The nuclear peroxisome proliferator-activated receptor γ has well-validated therapeutic potential in metabolic, inflammatory, and neurodegenerative pathologies, but its activation is also associated with marked adverse effects and novel modes of PPARγ modulation are required. Here, we report the discovery and profiling of a new PPARγ modulator chemotype endowed with remarkable potency and a distinct binding mode in the orthosteric PPARγ ligand-binding site. Its R-enantiomer evolved as a eutomer regarding PPARγ activation with a high eudysmic ratio. The new PPARγ modulator revealed outstanding selectivity over the PPARα and PPARδ subtypes and did not promote adipogenesis in primary human fibroblasts, discriminating it from established agonists.
Insights
Researchers discovered a novel compound that modulates peroxisome proliferator-activated receptor gamma (PPARγ). This compound shows potent activation and unique binding, offering a new therapeutic avenue with potentially fewer side effects.
Area of Science:
- Molecular biology
- Pharmacology
- Drug discovery
Background:
- Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor with therapeutic potential in metabolic, inflammatory, and neurodegenerative diseases.
- Current PPARγ activators are associated with adverse effects, necessitating novel modulation strategies.
Purpose of the Study:
- To discover and characterize a new chemical entity for PPARγ modulation.
- To investigate its binding mode, potency, selectivity, and functional effects.
Main Methods:
- Compound screening and profiling.
- Ligand-binding site analysis.
- Enantiomeric activity assessment.
- Selectivity profiling against PPAR subtypes.
- Adipogenesis assays in human fibroblasts.
Main Results:
- Discovery of a novel PPARγ modulator chemotype with high potency.
- Identification of a distinct binding mode within the PPARγ ligand-binding site.
- The R-enantiomer demonstrated superior PPARγ activation (high eudysmic ratio).
- The compound exhibited excellent selectivity over PPARα and PPARδ.
- No adipogenic effects were observed in primary human fibroblasts, differentiating it from existing agonists.
Conclusions:
- A new class of PPARγ modulators has been identified.
- This compound offers a distinct mechanism of action and improved selectivity profile.
- Potential for developing safer and more effective therapeutics targeting PPARγ-mediated pathways.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Peroxisomes